Finoriq research workspace
ACHIEVE LIFE SCIENCES, INC. (ACHV) Insider Transactions & Form 4 Activity
Track insider acquisitions, dispositions, options, RSUs, and Form 4 activity for ACHIEVE LIFE SCIENCES, INC. (ACHV).
Company Snapshot
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
- Company
- ACHIEVE LIFE SCIENCES, INC. (ACHV)
- Ticker
- ACHV
- Market Cap
- $639.6M
- Latest Price
- $6.23
- Industry
- Diagnostics
ACHIEVE LIFE SCIENCES, INC. (ACHV) Recent Insider Transactions
Recent market insider transaction records indexed for ACHIEVE LIFE SCIENCES, INC. (ACHV).
| Insider | Code | Value | Transaction Date |
|---|---|---|---|
| Oki Mark KChief Financial Officer | S | Disposed | -$146,175 | 2025-09-18 |
| Stewart Richard AlistairChief Executive Officer | S | Disposed | -$378,143 | 2025-09-18 |
| Wan JerryPrincipal Accounting Officer | S | Disposed | -$38,974 | 2025-09-04 |
| KING THOMAS BRAXTONCommon Stock | S | Disposed | -$387,407 | 2025-09-04 |
| JACOBS CINDYPresident & CMO | S | Disposed | -$76,532 | 2025-09-04 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.